ArticleHeliyon2020
On linear dimension reduction based on diagonalization of scatter matrices for bioinformatics downstream analyses.
Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Dimension reduction is often a preliminary step in the analysis of data sets with a large number of variables. Most classical, both supervised and unsupervised, dimension reduction methods such as principal component analysis (PCA), independent component analysis (ICA) or sliced inverse regression (SIR) can be formulated using one, two or several different scatter matrix functionals. Scatter matrices can be seen as different measures of multivariate dispersion and might highlight different features of the data and when compared might reveal interesting structures. Such analysis then searches for a projection onto an interesting (signal) part of the data, and it is also important to know the correct dimension of the signal subspace. These approaches usually make either no model assumptions or work in wide classes of semiparametric models. Theoretical results in the literature are however limited to the case where the sample size exceeds the number of variables which is hardly ever true for data sets encountered in bioinformatics. In this paper, we briefly review the relevant literature and explore if the dimension reduction tools can be used to find relevant and interesting subspaces for small-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.